All News

Society helps move progress forward in cancer research, causing one survivor to ask, “How can I pay back that debt?”

One person credits an entire oncology nurse team for going above and beyond during cancer treatment.

Lung cancer is a dangerous and often silent killer for the residents of northeast Georgia. For Dr. Arfoosh, lung cancer screening, quick referrals and prompt treatment for people with newly diagnosed lung cancer are at the forefront of his daily work.

A blood cancer survivor compares her journey to a rollercoaster and describes how she never knows what lies ahead.

One person describes an oncology nurse practitioner as one to give practical advice and guidance for everyone she encounters.

One oncology nurse shows the power of compassion and knowledge with every patient she cares for.

The study results demonstrated that patients with cancer had an elevated risk of all-cause mortality in the short-term if they experienced the onset of a mental health condition and were prescribed medicine for the condition shortly after their cancer diagnosis.

A woman who had an aesthetic flat closure after her mastectomy due to breast cancer explains what the new “Simpsons” character, Dr. Wendy Sage means to her.

From the deaths of Jovita Moore and Jerry Remy due to cancer, to Boyd Huppert’s myeloma diagnosis, here’s what’s happening in the cancer landscape this week.

After Kelsey Ahmed’s mother, Martha, was diagnosed with stage 4 non-small cell lung cancer, Kelsey and her family got to work raising funds and spreading awareness for the American Lung Association.

The Food and Drug Administration gave clearance to Bold Therapeutics for a phase 1b/2a trial examining treatments for advanced GI cancers.

Patients who experience side effects due to immune checkpoint inhibitors are 80% more likely to go to the emergency room and have 30% higher monthly medical costs, compared to patients who did not have side effects.

The FDA’s recommendations are aimed at helping individuals and patients with breast cancer make better informed decisions about the decision to receive breast implants, according to experts.

Seven years into a diagnosis of stage 4 breast cancer, one woman has also nurtured hope.

In this episode of CURE’s “Cancer Horizons” podcast, three individuals, who were recognized as CURE Lung Cancer Heroes, spoke about what the honor means to them and bringing the lung cancer community together.

By creating a community of survivors, researchers, physicians and clinicians, The White Ribbon Project — under Heidi Nafman-Onda’s direction — has influenced real change.

Cindy Cherry, MSN, AGNP-C, is an oncology nurse practitioner in Greenville, North Carolina. She treats patients with all types of cancers, including extensive-stage small cell lung cancer (ES-SCLC).

An expert discusses how the kidney cancer treatment landscape has changed over the last few years, although the number of options available for patients may make it somewhat confusing to navigate.

Patients with breast cancer are turning to medical marijuana to manage symptoms of their disease and treatment, although conversation with health care teams are not occurring as often.

A breast cancer survivor explains how a group of men made fun of her chest – which is flat due to a double mastectomy – and how she chose to laugh the rude comment away.

When cancer treatments stop working, it is not the end of the line. Most patients with advanced disease will be on continuous therapy, and that means trying different options along the way.

The risk for suicide increased after a cancer diagnosis and may last at least 10 years after, emphasizing how patients should seek mental health care as part of their journey.

After missing his flight, voice actor Rob Paulsen recorded a vlog in the airport where he discusses the “platinum lining” behind his cancer diagnosis when it comes to everyday hassles like travel.

One cancer survivor explains why a friend writes letters to his loved ones before each surgery “just in case.”

The FDA approval is based on ‘substantial’ disease-free survival results and may ‘drastically’ improve lung cancer survival.

Some patients with kidney cancer who are at a high risk of disease recurrence may benefit from adjuvant therapy; however, it is important recognize the potential side effects.

The first patients were dosed in a phase 2 trial for a topical gel to treat lesions in patients with colorectal cancer receiving EGFR inhibitor therapy.

The Food and Drug Administration will review parsaclisib for the treatment of patients with follicular lymphoma, marginal zone lymphoma and mantle cell lymphoma.

When patients with cancer are faced with receiving a prior authorization from their insurance provider for oral anticancer drugs, it is important that they advocate for themselves, according to an expert.

A young cancer survivor explains the importance of creating connections with others who have been through the same experiences.